We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
51
Regeneron Pharmaceuticals
REGN
$68.8B
$74.7M 0.43%
142,208
-72,733
-34% -$40.6M
VEEV icon
52
Veeva Systems
VEEV
$30.3B
$73.5M 0.42%
255,320
-76,902
-23% -$19.1M
CDNS icon
53
Cadence Design Systems
CDNS
$90B
$72M 0.42%
233,633
-49,347
-17% -$14.3M
AMD icon
54
Advanced Micro Devices
AMD
$851B
$71.7M 0.41%
505,423
-34,896
-6% -$3.8M
SYK icon
55
Stryker
SYK
$127B
$70.9M 0.41%
179,077
-4,190
-2% -$1.57M
INCY icon
56
Incyte
INCY
$23.5B
$70.2M 0.4%
1,031,121
+162,576
+19% +$10.3M
MS icon
57
Morgan Stanley
MS
$337B
$69.7M 0.4%
494,832
-30,367
-6% -$3.73M
WMT icon
58
Walmart Inc
WMT
$871B
$69.4M 0.4%
709,945
-19,055
-3% -$1.82M
ONC
59
BeOne Medicines Ltd
ONC
$33.8B
$67.9M 0.39%
280,286
-5,607
-2% -$1.38M
QCOM icon
60
Qualcomm
QCOM
$176B
$66.6M 0.38%
418,326
-6,274
-1% -$924K
CTAS icon
61
Cintas
CTAS
$82.4B
$66.5M 0.38%
298,207
-843
-0.3% -$181K
TRMB icon
62
Trimble
TRMB
$12.3B
$66.1M 0.38%
869,904
-1,757
-0.2% -$118K
ROK icon
63
Rockwell Automation
ROK
$51.4B
$65.5M 0.38%
197,072
-3,702
-2% -$1.05M
BNY
64
Bank of New York Mellon
BNY
$108B
$64.6M 0.37%
709,368
+29,699
+4% +$2.52M
XYL icon
65
Xylem
XYL
$28.5B
$64.4M 0.37%
498,043
+57,332
+13% +$6.94M
WELL icon
66
Welltower
WELL
$178B
$64.1M 0.37%
416,674
+10,584
+3% +$1.58M
BAC icon
67
Bank of America
BAC
$435B
$63.9M 0.37%
1,349,979
-42,850
-3% -$1.8M
A icon
68
Agilent Technologies
A
$39.1B
$63M 0.36%
533,466
+12,510
+2% +$1.39M
ADP icon
69
Automatic Data Processing
ADP
$100B
$62.5M 0.36%
202,602
+6,321
+3% +$1.94M
BNTX icon
70
BioNTech
BNTX
$22.6B
$62.5M 0.36%
586,736
-84,219
-13% -$8.51M
HCA icon
71
HCA Healthcare
HCA
$84.8B
$61.9M 0.36%
161,640
+5,069
+3% +$1.83M
UNH icon
72
UnitedHealth
UNH
$382B
$60.9M 0.35%
195,197
-96,561
-33% -$36.9M
MPWR icon
73
Monolithic Power Systems
MPWR
$65.5B
$58.8M 0.34%
80,346
+3,695
+5% +$2.35M
SPGI icon
74
S&P Global
SPGI
$126B
$58M 0.33%
109,959
-20,874
-16% -$10.4M
MDLZ icon
75
Mondelez International
MDLZ
$77.7B
$56.6M 0.33%
838,945
-142,944
-15% -$9.54M

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.